Showing results (1-10 of 100) with videos related to
Sort By:
Pageof 10
Transplantation|August 5, 2000
Reversible acute renal allograft dysfunction due to gabapentinB J Gallay, A M de Mattos, D J NormanClinical Transplantation|April 15, 1999
HLA-identical sibling renal transplantation--a 21-yr single-center experienceA M de Mattos, W M Bennett, J M Barry, et al.Transplantation|June 9, 1999
Renal transplantation across the ABO barrier using A2 kidneysA M Alkhunaizi, A M de Mattos, J M Barry, et al.Transplant Immunology|December 24, 1997
Interleukin-12 p40 m-RNA expression in human kidney allograft biopsiesA M de Mattos, M M Meyer, D J Norman, et al.Kidney International|June 22, 2006
Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factorsA M de Mattos, J Prather, A J Olyaei, et al.Transplantation|February 27, 1994
HLA-DR mismatching correlates with early cardiac allograft rejection, incidence, and graft survival when high-confidence-level serological DR typing is usedA M De Mattos, M A Head, J Everett, et al.Transplantation|January 11, 2001
Phase I trial of HuM291, a humanized anti-CD3 antibody, in patients receiving renal allografts from living donorsD J Norman, F Vincenti, A M de Mattos, et al.Drugs of Today (Barcelona, Spain : 1998)|March 11, 2004
Pharmacology of immunosuppressive drugsA J Olyaei, A M de Mattos, W M BennettAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 17, 2000
Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the futureA M de Mattos, A J Olyaei, W M BennettCurrent Opinion in Critical Care|January 24, 2002
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategiesA J Olyaei, A M de Mattos, W M BennettPageof 10